Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Non-interventional Study to Evaluate Quality of Life in Chinese Postmenopausal HR(+) EBC Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment

NCT01144572 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01144572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01144572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Non-interventional Study to Evaluate Quality of Life in Chinese Postmenopausal HR(+) EBC Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 31, 2010
Completion date
October 31, 2013
Enrollment
494 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer